JPMA’s Nakatani Says Transparency Guidelines Will Go into Force in April as Planned

Hiroaki Nakatani, senior managing director of the Japan Pharmaceutical Manufacturers Association (JPMA), said on February 21 that the association’s transparency guidelines will be implemented in April as scheduled despite concerns by doctors that the rule will undermine their personal information...read more